We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Neogen Corporation | NASDAQ:NEOG | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.13 | 0.97% | 13.54 | 13.25 | 13.84 | 13.74 | 13.21 | 13.41 | 2,408,419 | 22:43:21 |
LANSING, Mich., Dec. 21, 2023 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Thursday, January 11, 2024.
John Adent, Neogen's President and Chief Executive Officer, will present at 9:00 a.m. Pacific Time.
To access the webcast and presentation materials, please visit the Events & Presentations section of the Neogen Investor Relations website at neogen.com/investor-relations/events-presentations and click on the event webcast link.
About Neogen
Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.
Contact
Bill Waelke — VP, IR & Treasury
BWaelke@Neogen.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/neogen-to-participate-in-the-42nd-annual-jp-morgan-healthcare-conference-302020646.html
SOURCE Neogen Corporation
Copyright 2023 PR Newswire
1 Year Neogen Chart |
1 Month Neogen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions